| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Director | Common Stock | 124,546 | $4,860,906 | $39.03 | 26 May 2023 | Direct |
| CHINOOK THERAPEUTICS, INC. | Director | Stock Option (Right to Buy) | 13,300 | $347,396 | $26.12 | 26 May 2022 | Direct |
| CHINOOK THERAPEUTICS, INC. | Director | Restricted Stock Units | 0 | 26 May 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000120919123033189-haghighat-ross-2023-05-26 | CHINOOK THERAPEUTICS, INC. | 26 May 2023 | 2 | $0 | 4 | Director | 31 May 2023, 19:24 |
| /report/000089924322032796-haghighat-ross-2022-09-16 | Epiphany Technology Acquisition Corp. | 16 Sep 2022 | 0 | $0 | 3 | Co-Chief Executive Officer, Director | 04 Oct 2022, 19:58 |
| /report/000120919122032972-haghighat-ross-2022-05-26 | CHINOOK THERAPEUTICS, INC. | 26 May 2022 | 2 | $0 | 4 | Director | 31 May 2022, 18:47 |
| /report/000156761921021516-haghighat-ross-2021-12-02 | BioPlus Acquisition Corp. | 02 Dec 2021 | 0 | $0 | 3 | CEO and CFO, Director | 02 Dec 2021, 18:42 |
| /report/000120919121038799-haghighat-ross-2021-06-04 | CHINOOK THERAPEUTICS, INC. | 04 Jun 2021 | 1 | $0 | 4 | Director | 07 Jun 2021, 21:37 |